Cargando…

PEG skin testing for COVID-19 vaccine allergy

Detalles Bibliográficos
Autor principal:	Stone, Bryan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2021
Materias:	Correspondence and Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024682/ https://www.ncbi.nlm.nih.gov/pubmed/33838847 http://dx.doi.org/10.1016/j.jaip.2021.02.016

Ejemplares similares

Reply to “PEG skin testing for COVID-19 allergy”
por: Banerji, Aleena, et al.
Publicado: (2021)

Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines
por: Mathes, Sonja, et al.
Publicado: (2022)

Reply to “Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines”
por: Picard, Matthieu, et al.
Publicado: (2022)

Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines
por: Marchi, Francesco, et al.
Publicado: (2023)

How important is the second dose of the COVID-19 mRNA vaccine?
por: Liu, Anne Y.
Publicado: (2021)

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

Reply to “Does asthma affect outcomes of patients with COVID-19 infections?”
por: Mahdavinia, Mahboobeh, et al.
Publicado: (2021)

Mortality-related immune features and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?
por: Drake, Matthew G., et al.
Publicado: (2021)

Reply to “Mortality-related immune features and COVID-19”
por: Cai, Li, et al.
Publicado: (2021)

Does asthma affect outcomes of patients with COVID-19 infections?
por: Kalemci, Serdar, et al.
Publicado: (2021)

COVID-19 “infodemics” and asthmatic children: The return to school challenge
por: Boechat, José Laerte, et al.
Publicado: (2021)

Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium
por: Tricarico, Gerardo, et al.
Publicado: (2021)

Reply to “The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective”
por: Bansal, Priya, et al.
Publicado: (2021)

Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era
por: Mesli, Farah, et al.
Publicado: (2021)

Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium”
por: Ballow, Mark, et al.
Publicado: (2021)

Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era”
por: Lang, Claudia Cécile Valérie, et al.
Publicado: (2021)

Reply to “Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?”
por: Ferastraoaru, Denisa, et al.
Publicado: (2021)

Reply to “Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma”
por: Feng, Lan, et al.
Publicado: (2022)

Answer from the authors of the article “Skin manifestations of tick bites in humans” to Dr. Stefan Vilges de Oliveira and Dr. Álvaro A. Faccini-Martínez
por: Haddad Junior, Vidal, et al.
Publicado: (2019)

Risk of severe COVID-19 infection in International Space Station astronauts despite routine pre-mission measures
por: Javad Mortazavi, Seyed Mohammad, et al.
Publicado: (2021)

Reply to “Risk of severe COVID-19 infection in International Space Station astronauts despite routine pre-mission measures”
por: Crucian, Brian E., et al.
Publicado: (2021)

A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter
por: Maeda, Yohei, et al.
Publicado: (2022)

Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter"
por: Strauss, Ronald, et al.
Publicado: (2022)

Response to “Letter in response to ‘Students’ age and parental level of education influence COVID-19 vaccination hesitancy’”
por: Zychlinsky Scharff, Anna, et al.
Publicado: (2022)

P003 DIAGNOSTIC UTILITY OF PEG/POLYSORBATE 80 SKIN TESTING AND ORAL CHALLENGE FOR COVID-19 MRNA VACCINE ALLERGY
por: Ohtola, J., et al.
Publicado: (2021)

Reply to Borgia et al. Comment on “Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11, 1511”
por: Potestio, Luca, et al.
Publicado: (2022)

Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on “Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199”
por: Stuckelberger, Sarah, et al.
Publicado: (2021)

Reply to Çınar et al. Comment on “Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874”
por: Caruntu, Ana, et al.
Publicado: (2022)

Response to the Comment on “A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19”
por: González-Rubio, Jesus, et al.
Publicado: (2020)

Impact of more variations on in‐hospital mortality among patients with confirmed COVID‐19
por: Jia, Na, et al.
Publicado: (2022)

Reply to Ayuso García et al. Health Perception among Female COVID-19 Patients. Comment on “Fernández-de-las-Peñas et al. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022, 11, 413”
por: Fernández-de-las-Peñas, César, et al.
Publicado: (2022)

Reply: “Vitamin D Supplementation in Influenza and COVID-19 Infections. Comment on: Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths Nutrients 2020, 12(4), 988”
por: Grant, William B., et al.
Publicado: (2020)

Reply to: “Vitamin D Insufficiency May Account for Almost Nine of Ten COVID-19 Deaths: Time to Act. Comment on: Vitamin D Deficiency and Outcome of COVID-19 Patients. Nutrients 2020, 12, 2757”
por: Radujkovic, Aleksandar, et al.
Publicado: (2020)

A Flexible Lockdown by Integrating Public Health and Economic Reactivation to Response the Crisis of COVID-19: Responses to Comments by Alvaro J Idrovo on “An Examination on the Transmission of COVID-19 and the Effect of Response Strategies: A Comparative Analysis”
por: Chen, Yi-Tui, et al.
Publicado: (2020)

Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005”
por: Paynter, Janine, et al.
Publicado: (2019)

Reply: “Comment on: The Vitamin D–Folate Hypothesis as an Evolutionary Model for Skin Pigmentation: An Update and Integration of Current Ideas, Nutrients 2018, 10, 554”
por: Jones, Patrice, et al.
Publicado: (2018)

Response to Dr. Masaya Miyauchi and Dr. Teruhiko Imamura, Clinical implication of COVID‐19 associated bradycardia
por: Kumar, Sabina, et al.
Publicado: (2021)

Authors’ reply: the biologic importance of the vitamin D binding protein polymorphism in pediatric COVID-19 patients
por: Bayramoğlu, Elvan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ghgbkne1src2dkr1fo94ebm7lu